Mesa Laboratories Inc
NASDAQ:MLAB

Watchlist Manager
Mesa Laboratories Inc Logo
Mesa Laboratories Inc
NASDAQ:MLAB
Watchlist
Price: 109.85 USD -1.05% Market Closed
Market Cap: 596.5m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+32%
Revenue
Forecast
+8%
Operating Income
Forecast
+129%
Net Income
Forecast
N/A

Wall Street
Price Targets

MLAB Price Targets Summary
Mesa Laboratories Inc

Wall Street analysts forecast MLAB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MLAB is 144.5 USD with a low forecast of 121.2 USD and a high forecast of 168 USD.

MLAB Lowest Forecast
Wall Street Target
121.2 USD
10% Upside
MLAB Average Forecast
Wall Street Target
144.5 USD
32% Upside
MLAB Highest Forecast
Wall Street Target
168 USD
53% Upside
Lowest
Price Target
121.2 USD
10% Upside
Average
Price Target
144.5 USD
32% Upside
Highest
Price Target
168 USD
53% Upside
Mesa Laboratories Inc Competitors:
Price Targets
EUZ
Eckert & Ziegler Strahlen und Medizintechnik AG
3% Upside
LMAT
LeMaitre Vascular Inc
31% Upside
N
NAM
Namwiwat Medical Corp PCL
40% Upside
300760
Shenzhen Mindray Bio-Medical Electronics Co Ltd
37% Upside
EUZ
Eckert & Ziegler Strahlen und Medizintechnik AG
3% Upside
LMAT
LeMaitre Vascular Inc
31% Upside
N
NAM
Namwiwat Medical Corp PCL
40% Upside
300760
Shenzhen Mindray Bio-Medical Electronics Co Ltd
37% Upside
ALKLH
Klea Holding
191% Upside
DCTH
Delcath Systems Inc
42% Upside
I
ITGR
Integer Holdings Corp
27% Upside
688580
Nanjing Vishee Medical Technology Co Ltd
3% Upside

Revenue
Forecast

Revenue Estimate
Mesa Laboratories Inc

For the last 8 years the compound annual growth rate for Mesa Laboratories Inc's revenue is 12%. The projected CAGR for the next 3 years is 8%.

12%
Past Growth
8%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Mesa Laboratories Inc

For the last 8 years the compound annual growth rate for Mesa Laboratories Inc's operating income is -21%. The projected CAGR for the next 3 years is 129%.

-21%
Past Growth
129%
Estimated Growth
Estimates Accuracy
-6%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Mesa Laboratories Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-48%
Average Miss
What are analyst estimates?

See Also

Summary
MLAB intrinsic value, competitors valuation, and company profile.
DCF Valuation
MLAB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MLAB stock valuation using valuation multiples.
Wall Street Estimates
MLAB price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MLAB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MLAB's stock price target?
Price Target
144.5 USD

According to Wall Street analysts, the average 1-year price target for MLAB is 144.5 USD with a low forecast of 121.2 USD and a high forecast of 168 USD.

What is Mesa Laboratories Inc's Revenue forecast?
Projected CAGR
8%

For the last 8 years the compound annual growth rate for Mesa Laboratories Inc's revenue is 12%. The projected CAGR for the next 3 years is 8%.

What is Mesa Laboratories Inc's Operating Income forecast?
Projected CAGR
129%

For the last 8 years the compound annual growth rate for Mesa Laboratories Inc's operating income is -21%. The projected CAGR for the next 3 years is 129%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 256,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.